blood clots and semaglutide A recent study suggests that GLP-1 medications, commonly prescribed for managing diabetes obesity, may also lower the risk of dangerous clots. The study's lead author, Dr. Rushad Patell of Beth Vaccines and Rare Clotting Disorders:

(Ozempic is approved to treat Type 2 diabetes but can be prescribed off-label for weight loss.) And while many people benefit from these medications, I think doctors can learn from the fact that so many people give up on them, too

A test to check the medication adheres to endotoxin safety recommendations

Addressing nausea, vomiting, or diarrhoea early can help maintain normal hydration levels and support overall wellbeing throughout treatment

Some peptides do have FDA approval

Earlier this month, the medicines watchdog formally expanded its priority focus areas to include unapproved peptide products, making them a compliance priority for 2026

[3] [4] This flexibility accommodates patients who travel or prefer not to inject cold medication, which can cause injection site discomfort